BRWM
DNA icon

B. Riley Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

B. Riley Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$116K Buy
1,223
+925
+310% +$113K 0.01% 613
2022
Q1 		$48K Buy
+298
New +$58K ﹤0.01% 610

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

B. Riley Wealth Management's DNA Position: Q2 2022 in Review

B. Riley Wealth Management increased its Ginkgo Bioworks (DNA) stake by 310% in Q2 2022, buying an estimated $113K and bringing the position to 1,223 shares worth $116K. The position accounts for 0.01% of the portfolio, ranked #613.

B. Riley Wealth Management first reported a position in DNA in Q1 2022 and has held it in 2 quarters since. 260 funds tracked by Wall St. Rank hold DNA as of Q2 2022.

  • B. Riley Wealth Management held 1,223 shares of Ginkgo Bioworks worth $116K as of Q2 2022.
  • B. Riley Wealth Management bought 925 Ginkgo Bioworks shares in Q2 2022, an estimated $113K.
  • Ginkgo Bioworks made up 0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #613 holding.
  • B. Riley Wealth Management first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 2 quarters since.
  • 260 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.